Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darapladib outcomes study in chronic coronary heart disease
2008-005575-96Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Darapladib + standard of care with Placebo + standard of care (2 arms). Started Oct 2008; status: completed.
02
Drugs
darapladib
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-005575-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005575-96.